ArticleDrug metabolism and disposition: the biological fate of chemicals2014

Factors influencing the CNS distribution of a novel MEK-1/2 inhibitor: implications for combination therapy for melanoma brain metastases.

Shruthi Vaidhyanathan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.